Invention Application
- Patent Title: COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY
-
Application No.: US15404897Application Date: 2017-01-12
-
Publication No.: US20170119753A1Publication Date: 2017-05-04
- Inventor: Fabio RANCATI , Andrea RIZZI , Laura CARZANIGA , Ian LINNEY , Chris KNIGHT , Wolfgang SCHMIDT
- Applicant: CHIESI FARMACEUTICI S.p.A.
- Applicant Address: IT Parma
- Assignee: CHIESI FARMACEUTICI S.p.A.
- Current Assignee: CHIESI FARMACEUTICI S.p.A.
- Current Assignee Address: IT Parma
- Priority: EP15154917.7 20150212
- Main IPC: A61K31/4709
- IPC: A61K31/4709 ; A61K31/5386 ; A61K31/496 ; A61K9/00 ; A61K31/4704
Abstract:
Compounds of formula I, defined herein, act both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists and are useful for treating broncho-obstructive and inflammatory diseases.
Public/Granted literature
- US10004728B2 Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity Public/Granted day:2018-06-26
Information query
IPC分类:
